These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3021018)

  • 1. A quantitative decatenation assay for type II topoisomerases.
    Sahai BM; Kaplan JG
    Anal Biochem; 1986 Aug; 156(2):364-79. PubMed ID: 3021018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decatenation of kinetoplast DNA by topoisomerases.
    Marini JC; Miller KG; Englund PT
    J Biol Chem; 1980 Jun; 255(11):4976-9. PubMed ID: 6246090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A unique ATP-dependent DNA topoisomerase from trypanosomatids.
    Shlomai J; Zadok A; Frank D
    Adv Exp Med Biol; 1984; 179():409-22. PubMed ID: 6098160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A nicking enzyme from trypanosomatids which specifically affects the topological linking of duplex DNA circles. Purification and characterization.
    Shlomai J; Linial M
    J Biol Chem; 1986 Dec; 261(34):16219-25. PubMed ID: 3023345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA topoisomerase II-catalyzed DNA decatenation.
    Haldane A; Sullivan DM
    Methods Mol Biol; 2001; 95():13-23. PubMed ID: 11089215
    [No Abstract]   [Full Text] [Related]  

  • 6. DNA topoisomerases from rat liver: physiological variations.
    Duguet M; Lavenot C; Harper F; Mirambeau G; De Recondo AM
    Nucleic Acids Res; 1983 Feb; 11(4):1059-75. PubMed ID: 6298730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial topoisomerase II activity is essential for kinetoplast DNA minicircle segregation.
    Shapiro TA
    Mol Cell Biol; 1994 Jun; 14(6):3660-7. PubMed ID: 8196610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A DNA topoisomerase from trypanosomes able to catenate, decatenate and unknot DNA without ATP].
    Douc-Rasy S; Riou JF; Kayser A; Riou G
    C R Acad Sci III; 1986; 302(8):283-6. PubMed ID: 3011222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A homogeneous type II DNA topoisomerase from HeLa cell nuclei.
    Miller KG; Liu LF; Englund PT
    J Biol Chem; 1981 Sep; 256(17):9334-9. PubMed ID: 6267071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification and characterization of Plasmodium berghei DNA topoisomerases I and II: drug action, inhibition of decatenation and relaxation, and stimulation of DNA cleavage.
    Riou JF; Gabillot M; Philippe M; Schrevel J; Riou G
    Biochemistry; 1986 Apr; 25(7):1471-9. PubMed ID: 3011062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversible decatenation of kinetoplast DNA by a DNA topoisomerase from trypanosomatids.
    Shlomai J; Zadok A
    Nucleic Acids Res; 1983 Jun; 11(12):4019-34. PubMed ID: 6306572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decatenation of kinetoplast DNA by an ATP-dependent DNA topoisomerase from the kinetoplast hemoflagellate Leishmania donovani.
    Chakraborty AK; Majumder HK
    Mol Biochem Parasitol; 1987 Dec; 26(3):215-24. PubMed ID: 2828947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-molecule analysis uncovers the difference between the kinetics of DNA decatenation by bacterial topoisomerases I and III.
    Terekhova K; Marko JF; Mondragón A
    Nucleic Acids Res; 2014 Oct; 42(18):11657-67. PubMed ID: 25232096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An ATP-independent catenating enzyme from the kinetoplast hemoflagellate Leishmania donovani.
    Chakraborty AK; Majumder HK
    Biochem Biophys Res Commun; 1991 Oct; 180(1):279-85. PubMed ID: 1656969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A truncated form of DNA topoisomerase IIbeta associates with the mtDNA genome in mammalian mitochondria.
    Low RL; Orton S; Friedman DB
    Eur J Biochem; 2003 Oct; 270(20):4173-86. PubMed ID: 14519130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorometric assays for DNA topoisomerases and topoisomerase-targeted drugs: quantitation of catalytic activity and DNA cleavage.
    Andrea JE; Adachi K; Morgan AR
    Mol Pharmacol; 1991 Oct; 40(4):495-501. PubMed ID: 1656189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-throughput fluorescence flow-injection topoisomerase II inhibition assay.
    Barnabé N; Hasinoff BB
    J Chromatogr B Biomed Sci Appl; 2001 Sep; 760(2):263-9. PubMed ID: 11530985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ATP-independent DNA topoisomerase II as potential drug target in trypanosomes.
    Douc-Rasy S; Riou JF; Ahomadegbe JC; Riou G
    Biol Cell; 1988; 64(2):145-56. PubMed ID: 2852517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitoxantrone resistance in HL-60 leukemia cells: reduced nuclear topoisomerase II catalytic activity and drug-induced DNA cleavage in association with reduced expression of the topoisomerase II beta isoform.
    Harker WG; Slade DL; Drake FH; Parr RL
    Biochemistry; 1991 Oct; 30(41):9953-61. PubMed ID: 1655025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interlinked DNA nano-circles for measuring topoisomerase II activity at the level of single decatenation events.
    Kristoffersen EL; Givskov A; Jørgensen LA; Jensen PW; W Byl JA; Osheroff N; Andersen AH; Stougaard M; Ho YP; Knudsen BR
    Nucleic Acids Res; 2017 Jul; 45(13):7855-7869. PubMed ID: 28541438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.